Idiopathic intermediate uveitis in childhood

International Ophthalmology Clinics

Volumn 48, Issue 3, 2008, Pages 61-74

  Arellanes GarcÍa, Lourdes ^a   Navarro López, Patricia ^a   Río, Luz Elena Concha Del ^a   Unzueta Medina, Jose Antonio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETAMETHASONE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; DIPEPTIDYL CARBOXYPEPTIDASE; HLA DR ANTIGEN; HLA DR15 ANTIGEN; HLA DR2 ANTIGEN; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TRIAMCINOLONE;

BIOMICROSCOPY; BORRELIA BURGDORFERI; CATARACT; CHILD; CHORIORETINITIS; CILIARY DISK; CLINICAL FEATURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIRETINAL MEMBRANE; EXTRACAPSULAR CATARACT EXTRACTION; EYE EXAMINATION; FLUORESCENCE ANGIOGRAPHY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GLAUCOMA; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; IMMUNOGENETICS; IMMUNOMODULATION; INCIDENCE; INTERMEDIATE UVEITIS; INTRAOCULAR FOREIGN BODY; INTRAOCULAR HYPERTENSION; LABORATORY TEST; LENS IMPLANT; LEUKOCYTE DIFFERENTIAL COUNT; OPTIC DISK; OPTICAL COHERENCE TOMOGRAPHY; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RETINA MACULA CYSTOID EDEMA; RETINA NEOVASCULARIZATION; RETINA TEAR; REVIEW; SLIT LAMP; SURGICAL TECHNIQUE; THORAX RADIOGRAPHY; TOXOPLASMA; TREPONEMA PALLIDUM; UNSPECIFIED SIDE EFFECT; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS BODY; VITREOUS BODY DETACHMENT; VITREOUS HEMORRHAGE; ADOLESCENT; INFANT; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; UVEITIS, INTERMEDIATE;

EID: 51649114109     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e31817d84af     Document Type: Review

References (54)

1. Bloch-Michel E, Nussenblatt RB. International uveitis study group recommendations for the evaluation of intraocular inflammatory disease, Am J Ophthalmol- 1987;103: 234-235.
2. The Standarization of uveitis nomenclatura (SUN) working group. Standarization of uveitis nomenclature for reporting clinical data. Results of the first International Workshop. Am J Opthalmol. 2005; 140:509-516.
3. Fuchs E. In: Tasman W, Jaegar EA. Duane's Clinical Ophthalmology. Philadelphia: Lippincott Company; 1998:381-390.
4. Schepens CL. Examination of the Ora Serrata Region: its Clinical Signifiacance. Acta XVI Concilium Ophthalmologicum. (Britannia), London: British Association; 1950: 1.384-1.393.
5. Welch RB, Maumenne AE, Wahlen HE. Peripheral posterior segment inflammation, vitreous opacities, and edema of the posterior pole (pars planitis). Arch Ophthalmol. 1960; 64:540-549.
6. Gass JDM. Fluorescein angiography in endogenous intraocular inflammation. In: Aronson SB, ed. Clinical methods in uveitis. St Louis: Mosby Year Book Inc; 1968: 204-209.
7. Kaplan HJ, Tessler H, Goldstein DA. Classification of the intermediate uveitis. Minutes of the First Symposium American Uveitis Society, Breckenridge Co. January 1997. Ocul Immunol Inftam. 1997; 5:283-288.
8. Vadot E. Epidemiology of intermediate uveitis: a prospective study in Savoy. Dev Ophthalmol. 1992; 23:33-34.
9. Arellanes-García L, Navarro-López LP, Recillas-Gispert C. Pars planitis in the Mexican Mestizo population: ocular findings, treatment, and visual outcome. Ocul Immunol Inftam. 2003; 2:61-65.
10. Holland GN, Stiehm ER. Special consideration for the evaluation and management of uveitis in children. Am J Ophthalmol. 2003; 135:867-878.
11. Guest S, Funkhouser E, Lightman S. Pars planitis: a comparison of childhood onset and adult onset disease. Clin Exp Ophthalmol. 2001; 29:81-84.
12. Culbertson WW, Giles CL, West C, et al. Familial pars planitis. Retina. 1993; 3: 179-181.
13. Biswas J, Raghavendran SR. Intermediate uveitis of pars plana type in identical twins. Report of a case. Int Ophthalmol. 1998; 22:275-285.
14. Tejada P, Sanz A. Pars planitis in a family. Int Ophthalmol. 1994; 18:111-113.
15. Malinowski SM, Pulido JS, Goeken NE, et al. The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis. Ophthalmology. 1993; 100:1199-1205.
16. Raja S, Jabs D, Dunn JP, et al. Pars planitis. Clinical features and class II HLA Associations. Ophthalmology. 1999; 106:594-599.
17. Alaez C, Arellanes L, Vazquez A, et al. Classic pars planitis: strong correlation of class II genes with gender and some clinical features on Mexican Mestizos. Hum Immunol. 2003; 64:965-972.
18. Pederson JE, Kenyon KR, Green WR, et al. Pathology of pars planitis. Am J Ophthalmol. 1978; 86:762.
19. Yoser SL, Forster DJ, Rao NA. Pathology of intermediate uveitis. Dev Ophthalmol. 1992; 23:60-70.
20. Khodadoust AA, Karnama Y, Stoessel KM, et al. Pars planitis, an autoimmune endotheliopathy. Am J Ophthalmol. 1986; 102:633-639.
21. Tessler HH. Pars planitis and autoimmune endotheliopathy [Letter]. Am J Ophthalmol. 1987; 103:599.
22. Arellanes-Garcia L, Ortiz-Ponce G, Recillas-Gispert C. Peripheral corneal endotheliopathy and pars planitis. Ocular Immunol Inflamm. 1996; 3:135-138.
23. Davis JL, Bloch-Michel E. Intermediate uveitis. In: Pepose JS, Holland GN, Wilhelmus KR, et al. Ocular Infection and Immunity. St. Louis, MO: Mosby; 1996:676-693.
24. Capone A, Aaberg TM. Intermediate uveitis. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Philadelphia, Pennsylvania: W.B. Saunders; 1994:423-442.
25. Smith RE, Godfrey WA, Kimura SJ. Complications of chronic cyclitis. Am J Ophthalmol. 1976; 82:277-282.
26. Henderly DE, Haymond RS, Rao NA, et al. The significance of the pars plana exudate in pars planitis. Am J Ophthalmol. 1987; 103:669-671.
27. Boer J, Berendschot T, Van Der Does P, et al. Long-term follow-up of intermediate uveitis in children. Am J Ophthalmol. 2006; 141:616-621.
28. Arellanes L, García LM, Morales V, et al. Report of characteristic angiographic findings in a series of pars planitis patients. Invest Ophthalmol Vis Sci. 1992; 33: E-abstract 743.
29. Antcliff RJ. Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology. 2000; 107:593-599.
30. Hogan MJ, Kimura SJ, O'Connor GR. Ocular toxoplasmosis. Arch Ophthalmol. 1964; 72:592-600.
31. Berger BC, Leopold IH. The incidence of uveitis in multiple sclerosis. Am J Ophthalmol. 1987; 103:234-235.
32. Tamesis RR, Foster CS. Ocular syphilis. Ophthalmology. 1990; 97:1281-1287.
33. Breeveld J, Rothova A, Kuiper H. Intermediate uveitis and Lyme borreliosis. Br J Ophthalmol. 1993; 77:480-481.
34. Dugel PU, Smith RE. Pars planitis. In: Ryan SJ, Schachat AP, Murphy RP, et al. Retina, 2nd edn. St. Louis, MO: Mosby; 1994.
35. Bloch-Michel E. Opening Address: intermediate uveitis. Dev Ophthalmol. 1992; 23:1-2.
36. Malinowski SM, Pulido JS, Folk JC. Long-term visual outcome and complications associated with pars planitis. Ophthalmology. 1993; 100:818-825.
37. Felder KS, Brockhurst RJ. Neovascular fundus abnormalities in peripheral uveitis. Arch Ophthalmol. 1982; 100:750-754.
38. Pulido J, Mieler W, Walton D, et al. Results of peripheral laser photocoagulation in pars planitis. Trans Am Ophthalmol. 1998; 96:127-137.
39. Nozik RA. Periocular injection of steroids. Trans Am Acad Opthalmol Otolaryngol. 1972; 76:694-703.
40. Jabs D, Rosenbaum J, Foster S, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of a expert panel. Am J Ophthalmol. 2000; 130:492-513.
41. Wong VG, Hersh EM. Methotrexate in the therapy of cyclitis. Trans Am Acad Ophthalmol Otolaryngol. 1965; 69:279-293.
42. Samson M, Waheed N, Baltarzis S, et al. Methotrexate therapy for chronic noninfectious uveitis. Ophthalmology. 2001; 108:1134-1139.
43. Malik AR, Pavesio C. The use of low dose methotrexate in children with chronic anterior and intermediate uveitis. Br J Ophthalmol. 2005; 89:806-808.
44. Doycheva D, Deuter C, Stuebiger N, et al. Mycophenolate mofetil in the treatment of uveitis in children. Br J Ophthalmol. 2007; 9:180-184.
45. Kilmartin DJ, Forrester JV. Cyclosporin A therapy in refractory non-infectious childhood uveitis. Br J Ophthalmol. 1998; 82:737-742.
46. Rajaraman R, Kimura Y, Li S, et al. Retrospective case review of pediatric patients with uveitis treated with infliximab. Ophthalmology. 2006; 113:308-314.
47. Nussenblatt RB, Fortin E, Schiffman R, et al. Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAB: a phase I/II clinical trial. Proc Natl Acad Sci USA. 1999; 96:7462-7466.
48. Mohan N, Edwards ET, Cupps TR, et al. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthrides. Arthritis Rheum. 2001; 44: 2862-2869.
49. Potter M, Myckatyn S, Maberley A, et al. Vitrectomy for pars planitis complicated by vitreous hemorrhage: visual outcome and long-term follow up. Am J Ophthalmol. 2001; 131:514-515.
50. Michelson JB, Fiedlander MH, Nozik RA. Lens implant surgery in pars planitis. Ophtalmology. 1990; 97:1023-1026.
51. Tessler HH, Farber MD. Intraocular lens implantation versus no intraocular lens implantation in patients with chronic iridocyclitis and pars planitis; a randomized prospective study. Ophthalmology. 1993; 100:1206-1209.
52. Ganesh SK, Babu K, Biswas J. Phacoemulsification with intraocular lens implantation in cases of pars planitis. J Cataract Refract Surg. 2004; 30:2072-2076.
53. Foster CS. Cataract surgery and intraocular lens implantation in patients with intermediate uveitis. Dev Ophthalmol. 1992; 23:212-218.
54. Okhravi N, Morris A, Kok HS, et al. Intraoperative use of intravitreal triamcinolone in uveitic eyes having cataract surgery: pilot study. J Cataract Refract Surg. 2007; 33: 1278-83.